(Q38210272)

31 August 2017

title

PET imaging in multiple sclerosis (English)

1 reference

Carlos Alberto Buchpiguel

31 August 2017

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809810%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Daniele de Paula Faria

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809810%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Sjef Copray

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809810%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Rudi Dierckx

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809810%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Erik de Vries

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809810%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

9 May 2014

1 reference

Journal of Neuroimmune Pharmacology

31 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809810%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809810%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809810%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

468-482

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809810%20AND%20SRC:MED&resulttype=core&format=json

Imaging microglial/macrophage activation in spinal cords of experimental autoimmune encephalomyelitis rats by positron emission tomography using the mitochondrial 18 kDa translocator protein radioligand [¹⁸F]DPA-714.

2 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Feasibility of central cannabinoid CB1 receptor imaging with [124I]AM281 PET demonstrated in a schizophrenic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Cerebral metabolism in a case of multiple sclerosis with acute mental disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Structural and metabolic features of two different variants of multiple sclerosis: a PET/MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

18F-FDG PET detects inflammatory infiltrates in spinal cord experimental autoimmune encephalomyelitis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: implications for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: a comparison between [11C]CIC and [11C]MeDAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Evaluation of [(11)C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Can celecoxib affect P-glycoprotein-mediated drug efflux? A microPET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

PET visualization of microglia in multiple sclerosis patients using [11C]PK11195

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Personalized medicine in multiple sclerosis: hope or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

PET imaging of the peripheral benzodiazepine receptor: monitoring disease progression and therapy response in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Synthesis and biological evaluation of carbon-11- and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

MR imaging of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Characterization of PiB binding to white matter in Alzheimer disease and other dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Adenosine A(1) receptors using 8-dicyclopropylmethyl-1-[(11)C]methyl-3-propylxanthine PET in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Neurotransmitter receptors in the life and death of oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

In vivo imaging of brain estrogen receptors in rats: a 16α-18F-fluoro-17β-estradiol PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Quantitative analysis of adenosine A1 receptors in human brain using positron emission tomography and [1-methyl-11C]8-dicyclopropylmethyl-1-methyl-3-propylxanthine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Donepezil improved memory in multiple sclerosis in a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

The molecular basis of neurodegeneration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Radiolabeled COX-2 inhibitors for non-invasive visualization of COX-2 expression and activity--a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Neurodegeneration in multiple sclerosis: novel treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Brain imaging of multiple sclerosis: the next 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Central nervous system expression and PET imaging of the translocator protein in relapsing-remitting experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Multiple sclerosis: the disease and its manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Initial evaluation of 18F-GE-179, a putative PET Tracer for activated N-methyl D-aspartate receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Liver X receptors regulate cholesterol homeostasis in oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Translocator protein PET imaging for glial activation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Adenosine A(2A) receptor mediates microglial process retraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Functional imaging of a large demyelinating lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Functional basis of memory impairment in multiple sclerosis: a[18F]FDG PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Role of estrogen receptor beta in estrogen action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Increased PK11195 PET binding in the cortex of patients with MS correlates with disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Pathology of demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Synthesis and in vivo evaluation of [18F]-4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide as a PET imaging probe for COX-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Decreased microglial activation in MS patients treated with glatiramer acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Monoclonal antibody treatments for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Inflammation inhibits GABA transmission in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Role of MRI in diagnosis and treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

In vivo expression of cyclooxygenase-1 in activated microglia and macrophages during neuroinflammation visualized by PET with 11C-ketoprofen methyl ester.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Treatment of multiple sclerosis with the pregnancy hormone estriol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

PET and SPECT imaging of the NMDA receptor system: an overview of radiotracer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Neuroprotection mediated through estrogen receptor-alpha in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Imaging of CNS myelin by positron-emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-¹¹C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

White matter NMDA receptors: an unexpected new therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Will the real multiple sclerosis please stand up?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Clinical significance of reduced cerebral metabolism in multiple sclerosis: a combined PET and MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Donepezil improved memory in multiple sclerosis in a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Glucocorticoids regulate innate immunity in a model of multiple sclerosis: reciprocal interactions between the A1 adenosine receptor and beta-arrestin-1 in monocytoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Fluorinated COX-2 inhibitors as agents in PET imaging of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Principles of quantitative positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Cerebral acetylcholinesterase activity is not decreased in MS patients with cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Basics and principles of radiopharmaceuticals for PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

In vivo quantification of myelin changes in the vertebrate nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Estrogen receptor-β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

A novel fluorescent probe that is brain permeable and selectively binds to myelin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

A novel PET marker for in vivo quantification of myelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

PET imaging of inflammation biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Longitudinal positron emission tomography imaging for monitoring myelin repair in the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

[(11)C]DAC-PET for noninvasively monitoring neuroinflammation and immunosuppressive therapy efficacy in rat experimental autoimmune encephalomyelitis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

LXR agonists: new potential therapeutic drug for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Role of cannabinoids in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Principles of nuclear medicine imaging: planar, SPECT, PET, multi-modality, and autoradiography systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-014-9544-2

Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain

21 January 2018

1 reference

12 December 2020

Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosis

1 reference

12 December 2020

Positron emission tomography with 11C-flumazenil in the rat shows preservation of binding sites during the acute phase after 2h-transient focal ischemia

1 reference

12 December 2020

Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

1 reference

12 December 2020

Diagnosis and differential diagnosis of multiple sclerosis

1 reference

12 December 2020

PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Pathology and disease mechanisms in different stages of multiple sclerosis

1 reference

12 December 2020

Radiosynthesis, in vitro validation, and in vivo evaluation of 18F-labeled COX-1 and COX-2 inhibitors.

1 reference

12 December 2020

Systemic and cerebral kinetics of 16 alpha [18F]fluoro-17 beta-estradiol: a ligand for the in vivo assessment of estrogen receptor binding parameters

1 reference

12 December 2020

Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis

1 reference

12 December 2020

Synthesis and in vivo evaluation of 18F-desbromo-DuP-697 as a PET tracer for cyclooxygenase-2 expression

1 reference

12 December 2020

Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis

1 reference

12 December 2020

Presentation of alpha B-crystallin to T cells in active multiple sclerosis lesions: an early event following inflammatory demyelination

1 reference

12 December 2020

High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis

1 reference

12 December 2020

Alphab-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions

1 reference

12 December 2020

Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells

1 reference

12 December 2020

Pregnancy and multiple sclerosis

1 reference

12 December 2020

Clinical implications of neuropathological findings in multiple sclerosis

1 reference

12 December 2020

Synthesis, biological evaluation, and baboon PET imaging of the potential adrenal imaging agent cholesteryl-p-[18F]fluorobenzoate

1 reference

12 December 2020

Gray Matter Pathology in MS: Neuroimaging and Clinical Correlations

1 reference

12 December 2020

Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.

1 reference

12 December 2020

High cholesterol level is essential for myelin membrane growth

1 reference

12 December 2020

Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis

1 reference

12 December 2020

PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [11C]MeDAS, [11C]CIC and [11C]PIB

1 reference

12 December 2020

The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity

1 reference

12 December 2020

10.1007/S11481-014-9544-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809810%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 June 2020

1047218205

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24809810%20AND%20SRC:MED&resulttype=core&format=json